tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BriaCell’s Phase 3 Data Shows Promise for Metastatic Breast Cancer Treatment
Company AnnouncementsBriaCell’s Phase 3 Data Shows Promise for Metastatic Breast Cancer Treatment
5d ago
BCTX
BriaCell presents preclinical data from Phase 3 study of Bria-IMT
PremiumThe Fly
BriaCell presents preclinical data from Phase 3 study of Bria-IMT
5d ago
BCTX
BriaCell Therapeutics Closes $13.8 Million Public Offering
PremiumCompany Announcements
BriaCell Therapeutics Closes $13.8 Million Public Offering
7d ago
BCTX
BriaCell’s Breakthrough in Cancer Immunotherapy at AACR 2025
PremiumCompany Announcements
BriaCell’s Breakthrough in Cancer Immunotherapy at AACR 2025
7d ago
BCTX
BriaCell presents data from Phase 2 study of Bria-IMT
PremiumThe Fly
BriaCell presents data from Phase 2 study of Bria-IMT
7d ago
BCTX
BriaCell 3.07M share Secondary priced at $4.50
PremiumThe FlyBriaCell 3.07M share Secondary priced at $4.50
10d ago
BCTX
BriaCell Therapeutics Announces $13.8 Million Public Offering
Premium
Company Announcements
BriaCell Therapeutics Announces $13.8 Million Public Offering
10d ago
BCTX
BriaCell’s Bria-OTS Shows Promising Results in Metastatic Breast Cancer Study
Premium
Company Announcements
BriaCell’s Bria-OTS Shows Promising Results in Metastatic Breast Cancer Study
11d ago
BCTX
BriaCell confirms 100% resolution of lung metastasis with Bria-OTS
PremiumThe Fly
BriaCell confirms 100% resolution of lung metastasis with Bria-OTS
11d ago
BCTX
BriaCell to Present Key Clinical Data at ASCO 2025
PremiumCompany Announcements
BriaCell to Present Key Clinical Data at ASCO 2025
12d ago
BCTX
BriaCell files to sell 2.33M common units
PremiumThe Fly
BriaCell files to sell 2.33M common units
13d ago
BCTX
BriaCell Therapeutics: Promising Phase 3 Trial Progress and Strategic Financial Management Justify Buy Rating
PremiumRatings
BriaCell Therapeutics: Promising Phase 3 Trial Progress and Strategic Financial Management Justify Buy Rating
13d ago
BCTX
BriaCell Advances Phase 3 Study in Metastatic Breast Cancer
PremiumCompany AnnouncementsBriaCell Advances Phase 3 Study in Metastatic Breast Cancer
13d ago
BCTX
BriaCell announces ongoing Phase 3 study enrolled over 75 patients
Premium
The Fly
BriaCell announces ongoing Phase 3 study enrolled over 75 patients
13d ago
BCTX
BriaCell’s Phase 2 Study Shows Promising Survival Data in Breast Cancer
Premium
Company Announcements
BriaCell’s Phase 2 Study Shows Promising Survival Data in Breast Cancer
19d ago
BCTX
BriaCell announces survival data from its Phase 2 study of Bria-IMT
PremiumThe Fly
BriaCell announces survival data from its Phase 2 study of Bria-IMT
19d ago
BCTX
BriaPro Advances Novel Anti-Cancer Antibody Development
PremiumCompany Announcements
BriaPro Advances Novel Anti-Cancer Antibody Development
25d ago
BCTX
BriaCell’s BriaPro develops antibodies to anti-cancer target B7-H3
PremiumThe Fly
BriaCell’s BriaPro develops antibodies to anti-cancer target B7-H3
25d ago
BCTX
BriaCell to Showcase Cancer Immunotherapy Advances at AACR 2025
PremiumCompany Announcements
BriaCell to Showcase Cancer Immunotherapy Advances at AACR 2025
1M ago
BCTX
BriaCell’s Phase 3 Metastatic Breast Cancer Study Receives Positive DSMB Review
PremiumCompany AnnouncementsBriaCell’s Phase 3 Metastatic Breast Cancer Study Receives Positive DSMB Review
2M ago
BCTX
BriaCell says second DSMB recommends continuation of Phase 3 study in MBC
Premium
The Fly
BriaCell says second DSMB recommends continuation of Phase 3 study in MBC
2M ago
BCTX
BriaCell Therapeutics Reports Continued Financial Challenges
Premium
Company Announcements
BriaCell Therapeutics Reports Continued Financial Challenges
2M ago
8K
BCTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >